Remaining questions on the management of HER2-low breast cancer VJOncology 0:56 1 year ago 156 Скачать Далее
Questions remaining in the field of HER2-low breast cancer VJOncology 1:33 1 year ago 531 Скачать Далее
Remaining questions surrounding HER2-low breast cancer – how low can you go? VJOncology 2:13 1 year ago 311 Скачать Далее
Overview of the management of HER2-low breast cancer patients ecancer 7:13 1 year ago 127 Скачать Далее
HER2-Low Breast Cancer: DESTINY or Good Science? Cancer Treatment Updates 11:12 6 months ago 15 641 Скачать Далее
A New View of the Spectrum of HER2 Expression and Significance of HER2 Low in Breast Cancer PeerView Oncology 1:25:22 1 year ago 2 272 Скачать Далее
The Science of HER2-low Breast Cancer and Implications for the Pathology Team ASCP 54:43 2 years ago 2 702 Скачать Далее
Optimizing the Identification of HER2-Low Breast Cancer Research To Practice 23:49 3 days ago 14 Скачать Далее
Expert Report on advances in the management of HER2-negative and HER2-low advanced breast cancer European Society for Medical Oncology (ESMO) 6:39 2 years ago 3 287 Скачать Далее
HER2-low breast cancer: the ESMO Expert Consensus Statements European Society for Medical Oncology (ESMO) 2:02 1 year ago 943 Скачать Далее
Clinical outcomes in women with metastatic HER2-low breast cancer in the real world VJOncology 1:17 2 years ago 190 Скачать Далее
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis ecancer 2:30 1 year ago 199 Скачать Далее
Dr. Hamilton on the Efficacy of Trastuzumab Deruxtecan in HER2-Low Breast Cancer OncLive 1:13 3 years ago 330 Скачать Далее
HER2-Low Expression in Breast Cancer: Opportunities for Expanding Treatment Benefit to More Patients PeerView Oncology 1:20:02 1 year ago 2 891 Скачать Далее
